(HTLV-I and HTLV-II) are type C retroviruses which, along with simian T-cell lymphoma/leukemia virus type I (STLV-I), can be referred to as the primate T-cell lymphoma/ leukemia viruses (PTLV). HTLV-I is the etiologic agent of adult T-cell leukemia/lymphoma, HTLV-I-associated myelopathy, and HTLV-I-associated polymyositis (4, 35, 44a, 53, 54) . Although HTLV-II has been isolated from patients with unusual lymphocytic leukemias (6a, 22, 28, 37) and myelopathies (19, 20) , the etiological role of this virus in any disease is yet to be established. HTLV-II (MoT), one of the two original HTLV-II isolates, has been characterized in detail at the molecular level (5, 46, 47, 50) . Recently, HTLV-II has been found to be endemic in several American Indian tribes throughout the Western Hemisphere (6, 14a, 21, 25, 34a) . HTLV-II has also been found to be prevalent in intravenous drug users (11, 26) . While the genetic diversity and phylogeny of HTLV-I have been studied extensively (8, 10, 13, 16, 17, 29, 30, 36, 40, 44, 45) , there is a paucity of knowledge regarding the evolution of HTLV-II. However, it is well accepted that HTLV-II diverged from HTLV-I and * Corresponding author.
STLV-I many millennia ago (10, 13, 15-18, 36, 39, 40, 45) . Hence, we have designed a study to examine the heterogeneity among different HTLV-II isolates from several randomly chosen HTLV-II-infected individuals from the Western Hemisphere, including isolates from a Seminole Indian and a Guaymi Indian (34a) and a Tobas Indian (14a).
Virus-encoded reverse transcriptase is essential for the completion of the retroviral life cycle (51) . Hence, there are selective pressures on the PTLV pol gene that maintain sequence conservation over time. While evidence of multiple recombinations of env sequences among distantly related retroviruses exists, pol sequences have been shown to more reliably reflect their phylogenetic relationships (30) . We have previously shown that DNA amplification by the polymerase chain reaction (PCR) with the primer pair SK110/SK111 [also called HTIIP(4735-4756)+/HTIIP(4920-4897)-] (24) , which is homologous to a region conserved in the pol genes of all the PTLV and flanks regions of both conservation and variability, can be used to quickly detect and analyze PTLV isolates for sequence diversity (24, 28, 39, 45) . In DNA was extracted and purified from cultured [only HTLV-I (AJ5740)] or fresh peripheral blood mononuclear cells as previously described (1) . The patients were found to be positive for HTLV-I or HTLV-II antibodies by a whole-HTLV-I enzyme-linked immunosorbent assay (ELISA) (Cellular Products, Buffalo, N.Y.), which was confirmed by Western blot (immunoblot) and radioimmunoprecipitation assays with HTLV-I-infected cell lysates (12) according to U.S. Public Health Service criteria (2) . Type-specific infection was determined serologically by a peptide-based ELISA (28, 48) Enzymatic amplification of DNA. Enzymatic amplifications of the HTLV-II and HTLV-I DNAs were performed, per previously described methods, by using a battery of physical and procedural safeguards, including uracil-N-glycosylase sterilization (27) , to ensure that carryover did not occur (1) . The specific primer-probe sets utilized are listed in Table 1 (1, 10, 12, 24, 40, 45) . Positive and negative DNA and reagent controls were included in all reactions. Amplifications were for 30 and, if negative, then 60 cycles.
Hybridization analyses of amplified DNA. All amplified DNAs were subjected to liquid hybridization or Southern blot analysis by using the respective end-labelled detectors to verify that the regions amplified corresponded to specific HTLV-I or HTLV-II genes (1, 10, 12, 24, 40, 45) .
Cloning and sequencing amplified DNA. The linker sequences 5'-ACAGGTACCTGCAGATCTAGA-3', which contains a KpnI site, and 5'-TACGAGCTCGCGAATT CATGA-3', which contains an SstI site, were synthesized on the 5' ends of the positive-and negative-strand primers, respectively. The amplified DNA was digested with SstI and KpnI and then ligated to a similarly digested M13mpl8 vector, as described elsewhere (40, 45) . Alternatively, the amplified double-stranded DNA was ligated to the plasmid (40) . In the instances in which dUMP was incorporated into PCR products, E. coli KT8052, which does not produce uracil-N-glycosylase, was utilized (23) . Clones were selected after plaque hybridization with the appropriate 32P-labelled oligonucleotide probe. Single-stranded template DNA was prepared and used for nucleotide sequencing (41) with a Sequenase Version 2.0 kit (United States Biochemical) by the manufacturer's protocol. For double-stranded DNA sequencing, plasmid DNA was prepared by a method described elsewhere (9) .
Dendrogram analyses. Sequence alignments and comparisons were made as described above (7, 33) . Two methods, the unweighted pair-group method of association (UPGMA) (34) and the PAUP program (49) , were used to compare new and previously published STLV-I, HTLV-I, and HTLV-II pol sequences, including STLV-I (Tan9O) (39), HTLV-I (7ACD) (44b), HTLV-I (NIH-CTCL-11) (31), HTLV-I (PNG-1) and HTLV-I (HSC-CTCL-11B) (45) , and HTLV-II (Seminole) and HTLV-II (Guaymi) (34a). Dendrograms were constructed to delineate the evolutionary relationships among these different virus isolates. Bootstrap (14, 55) estimation of phylogenetic variability using 20 replications was performed on the trees generated by the PAUP program, and a consensus tree indicating the most likely branch points among the PTLV was generated.
Further, in order to evaluate the relative rate (42) of divergence of pol sequences flanked by SK110 and SK111 among various PTLV after particular branch points, three comparisons were made. First, the divergence between all HTLV-I and STLV-I isolates and BLV was compared with the divergence of all HTLV-II isolates and BLV. Second, the rate of divergence of the two HTLV-II substrains from BLV was determined. Finally, the rate of divergence of the two HTLV-II substrains from all HTLV-I and STLV-I isolates was determined. Statistical analyses were performed by the chi-square technique.
Nucleotide sequence accession numbers. The GenBank accession numbers of the HTLV pol fragments sequenced in this study (see Fig. 2 ) are as follows: HTLV-II pol sequences, M99067, isolate AM16497; M99068, CS29367; M99069, DM15489; M99070, FF30803; M99071, HP26157; M99072, JB16453; M99073, JP16341; M99074, KC16498; M99075, PK15098; M99076, RA15893; M99077, RC23723; M99078, RC23743; M99079, RH21528; M99080, RW30730; and M99081, WC17133; HTLV-I pol sequences, M99082, 7ACD; M99083, AM16497; M99084, AJ5740; M99085, AM16163; M99086, NIH-CTCL-11; M99087, G17654; and M99088, JM15559. The accession numbers of the HTLV-II (RC23723) LTR, gp35env, gp2oev, and pX ORF-II DNAs (see Fig. 4 amplified by primer pair SK1l0/SK11l (Fig. 1) indicate that the sequence heterogeneity in the DNA flanked by this primer pair reflects the overall sequence diversity for the entire genome among PTLV isolates (r = 0.998) and among all retroviruses analyzed (r = 0.980). This observation holds within HTLV-I isolates (r = 0.954) and also if one compares PTLV LTR and SK1l0/SK11l sequences (r = 0.995) (Fig.  1 (Fig. 3) . Aside from the fact that all three HTLV-II isolates from Amerindians belong to the same substrain, there was no other common pattern among the patients in terms of geographic origin, race, or known retroviral risk factors to allow for segregation of these isolates (Fig. 3) . However, although the number of isolates is still quite small for proper analysis, it is interesting to note that all five patients with either lymphocytic leukemia or myelopathy were infected with the HTLV-II substrain most closely related to the prototype HTLV-II (MoT) isolate (Fig. 3) .
Comparison between HTLV-1 and HTLV-II isolates from the New World indicates that there is considerably more divergence (albeit bimodal) among HTLV-11 isolates than among HTLV-1 strains. In fact, the range of divergence observed in Western Hemisphere HTLV-II isolates is comparable to that shown among cosmopolitan HTLV-I and STLV-I isolates ( Fig. 2 and 3 ). It is doubtful that the degree of divergence seen between the various strains and substrains of the PTLV is secondary to postbranching differential mutation rates because there was no statistical difference in the following comparisons: (i) all HTLV-1 and STLV-I strains and BLV (divergence, 42 efficiently than other strains. All HTLV-II isolates could be amplified and detected with the majority of primer pairprobe sets, although 60 cycles of amplification were required in some instances. Two of the HTLV-II isolates, JP16341 and FF30803, were negative for two and three of the HTLV-II primer-probe sets, respectively. On the basis of previous experience (10, 40, 45) , negative or inefficient PCR results are indicative of sequence variability or a defective provirus within the DNA flanked by the primers.
The isolate HTLV-II (RC23723) was chosen for further sequence analyses because it was subtyped as the most divergent isolate of the Paleo-Amerindian substrain according to the 140 bp of the pol gene presented above and because it could be amplified with all of the HTLV-II primer pairs used. A total of 76 (5.4%) nucleotide changes were observed among 1,410 bases sequenced throughout the HTLV-II (RC23723) genome. Sequence analysis was performed on 575 bp located within this isolate's LTR (Fig. 4) . Comparison with the prototype isolate, HTLV-II (MoT), showed 41 nucleotide changes for a divergence of 6.28%. Of the sequence changes in HTLV-II (RC23723) shown in Fig.  4 , 37.8% were clustered in the U3 region and 62.16% were in the R and U5 regions. Overall, there were 29 single-base substitutions, 10 deletions, and two single-base insertions. The ratio of transitions to transversions was 1.23. C-*T (5 of 15) and C->G (3 of 13) were the predominant transitions and transversions, respectively.
Most of the diversity observed in the HTLV-II (RC23723) LTR sequence was confined to regions with theoretically minimal impact on viral replication. All of the known essential functional characteristics of a PTLV LTR were conserved. Interestingly, few changes were noted in any of the following regulatory elements which are involved in the regulation of gene expression and replication of the PTLV.
(i) Only two changes (C-*A and T-*C) were noted in the second of the two 21-bp imperfect repeat enhancer elements in the region upstream of the TATAA box. Interestingly, these same two changes were observed in the HTLV-II (Seminole) and HTLV-II (Guaymi) isolates (34a). (ii) A poly(A) signal, ATAAA, located 268 bases upstream of the poly(A) site was unchanged. (iii) Minimal changes were observed in the R region from hucleotide 450 to 504, preserving the formation of a stem-loop RNA secondary structure required for polyadenylation and efficient Rex protein binding. It is to be noted that Rex augments cytoplasmic levels of unspliced viral mRNA by acting through a Rexresponsive element in the LTR (5). (iv) The cap site of HTLV-II mRNA at the U3-R boundary (GGAGGT) was unchanged. (v) The substitutions at positions 132 and 215 disrupt potential CpG DNA methylation sites, while the change at position 194 creates such a site upstream of the TATAA box-promoter. Again, the same changes were observed in the HTLV-II (Seminole) and HTLV-II (Guaymi) isolates (34a) . Figure 4 shows the comparison of prototype HTLV-II (MoT) and HTLV-II (RC23723) sequences from the 5' region of the env gene which encodes the surface membrane protein, gp35. Seventeen We also amplified and sequenced the region of the env gene which encodes part of the transmembrane portion of the envelope protein, gp2O (Fig. 4) . When HTLV-I1 (RC23723) was compared with the prototype isolate, HTLV-II (MoT), seven changes out of 286 bp sequenced were detected. All of the changes were transitions, and one of the seven was nonsynonymous, with phenylalanine being replaced by serine.
Finally, a protein-coding region in the pX gene (pX ORF-II) of HTLV-II was amplified, and 119 bp of this region in RC23723 was sequenced (Fig. 4) . Only one change from HTLV-II (MoT) was detected in HTLV-II (RC23723). It was a nonsynonymous A->G transition replacing threonine with valine. Interestingly, this same change was observed in the HTLV-II (Seminole) and HTLV-II (Guaymi) isolates (34a).
DISCUSSION
The two original isolates of HTLV-IL (MoT and NRA) were obtained from patients with atypical hairy cell leukemia and, in the case of NRA, CD8-positive T-cell leukemia (22, 37) . Only HTLV-II (MoT) has been characterized in detail, and the entire sequence of this strain has been published (46) . In the present study, DNAs from 17 (Fig. 1) . Further, we have confirmed these results by performing comparative sequence analyses of an additional 1,270 bp from the LTR, env, andpX genes of one representative isolate from each of the two subtypes. It is Results from our laboratory and others (10, 16-18, 36, 39, 40, 45) suggest that the PTLV group has apparently evolved at a relatively (e.g., compared with human immunodeficiency virus) slow and uniform rate, with HTLV-II diverging from a common ancestor of both STLV-I and HTLV-I tens of thousands of years ago. The dendrograms presented here also support the hypothesis of an ancient separation of HTLV-I and HTLV-II. It has been proposed that STLV-I and HTLV-I originated in Asia, Africa, the archipelagos of the East Indies, or Australia and through vertical and horizontal transmission were spread from there throughout Africa, Melanesia, the New World, and Japan (16, 17, 39, 40, 45) . HTLV-I is believed to have been brought into the Western Hemisphere about 400 years ago by European slave traders (10, 15, 17, 29, 36, 39, 40, 45) .
In contrast, because it has been found to be indigenous to American Indian populations (6, 14a, 21, 25, 34a) , HTLV-II may have arrived in the Western Hemisphere 10,000 to 50,000 years ago with the waves of early migrants who came from Siberia via the Bering land bridge. If this hypothesis is correct, one should expect more diversity among different HTLV-II isolates than among HTLV-I isolates from the Americas.
The HTLV-I (PNG-1) strain was grown from the peripheral blood of a man who belonged to an isolated group in Papua New Guinea, the Hagahai (40, 45) . The Hagahai have been separated from other humans for thousands of years. The STLV-I (Tan9O) isolate was obtained from a wild tantalus monkey captured in the Central African Republic (39) . Hence, it is thought that the degree of diversity observed between HTLV-I (PNG-1), STLV-I (Tan9O), and cosmopolitan HTLV-I isolates must be secondary to thousands of years of viral evolution, reflective of their long period of separation. Since the degree of diversity seen among randomly selected Western Hemisphere HTLV-II isolates is as great as that seen between HTLV-I (PNG-1), STLV-I (Tan9O), and the New World HTLV-I isolates, we could conclude that the heterogeneity seen among the HTLV-II isolates also represents many thousands of years of evolution. Of course, this conclusion is based on the assumption, supported by our data, that the net effects of mutation rates and selective pressures are similar for HTLV-I and HTLV-II. If this conclusion were true and since the same degree of diversity is not seen in randomly selected North American HTLV-I isolates, it would seem unlikely that HTLV-II could have been brought to the Western Hemisphere by a single group of Europeans or Africans. Rather, it would seem most probable that HTLV-II was present in the indigenous Amerindian population and/or that it was present in diverse forms among the immigrants to the New World. The facts that HTLV-II is endemic in many different Amerindian groups and that the Guaymi and Tobas Indians have remained isolated from Europeans and Africans for the past 500 years (3, 52) indicate that at least HTLV-II subtype B was present in the pre-Columbian Amerindian population. Further analyses of PTLV isolates from around the world will clarify this issue, and careful clinical and in vitro studies will elucidate the biological importance of the observed sequence diversity.
